OMB control number
Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products
OMB 0910-0675 · HHS/FDA.
OMB 0910-0675
The information collection supports agency recommendations for manufacturers regarding the development and maintenance of a plan for ensuring the availability of medically necessary drug products. In addition, the information collection supports recommendations that manufacturers include a procedure in their plan when the plan is activated and when returning to normal operations and that these notifications occur within one day of a plan's activation and within one day of a plan's deactivation.
The latest form for Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products expires 2023-04-30 and is listed under ICR 202004-0910-005.
Latest Forms, Documents, and Supporting Material
| Document | Type |
|---|---|
 0675 Planning for high absenteeism SSA 2020 EXT.pdf | Supporting Statement A |
 Recordkeeping; developing and updating plan |
Other-Agency Guidance |
| Reporting; Notify FDA of Plan Activation and Deactivation |
Other-Agency Guidance |
All Historical Document Collections
| Reference | Filing | Received | Concluded | Action |
|---|---|---|---|---|
| 202004-0910-005 | Extension without change of a currently approved collection | 2020-04-27 | Approved without change | |
| 201703-0910-008 | Extension without change of a currently approved collection | 2017-03-15 | Approved without change | |
| 201401-0910-002 | Extension without change of a currently approved collection | 2014-01-10 | Approved without change | |
| 201011-0910-001 | New collection (Request for a new OMB Control Number) | 2010-11-02 | Approved without change |
OMB Details
Reporting; Notify FDA of Plan Activation and Deactivation
Federal Enterprise Architecture: Health - Consumer Health and Safety